Contract 1409245

McKesson Drug Company, headquartered in Dallas, Texas, has been awarded a contract (1409245) by the Department of Veterans Affairs for pharmaceutical services or medical supply distribution. The contract, valued at $8,104.00, is scheduled to run from December 31, 2025, with an extended completion date of January 1, 2099, suggesting a long-term strategic partnership for medical supply or pharmaceutical procurement.

The contract, designated with type code "ZO", is specific to the State of Nebraska and appears to be a standing agreement for ongoing medical supply or pharmaceutical product delivery. While specific product details are not provided, McKesson's primary business in pharmaceutical distribution indicates the likely scope involves medical or pharmaceutical product supply to Veterans Affairs facilities within Nebraska. The extended performance period and relatively modest annual value suggest this may be a specialized or supplemental procurement supporting veteran healthcare infrastructure.